Canopy Growth (CGC) EBITDA (2019 - 2025)
Canopy Growth's (CGC) quarterly EBITDA came in at -$18.9 million in Q4 2025, down 10.8% year-on-year from -$21.2 million in Q4 2024, and down 53.92% quarter-over-quarter from -$12.3 million in Q3 2025.
Canopy Growth (CGC) EBITDA (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed EBITDA across 7 years of filings, most recently posting -$18.9 million for Q4 2025.
- EBITDA for Q4 2025 came in at -$18.9 million, down 10.8% year-over-year; the trailing twelve-month figure through Dec 2025 was -$88.8 million (up 41.25% YoY), and the FY2025 annual result was -$110.3 million, up 35.04% from the prior year.
- EBITDA came in at -$18.9 million for Q4 2025 at Canopy Growth, down from -$12.3 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $297.1 million in Q2 2021 to a low of -$1.6 billion in Q2 2022.
- The 5-year median for EBITDA is -$60.3 million (2024), against an average of -$196.7 million.
- Across the five-year window, EBITDA surged 332.72% in 2021 and plunged 1339.59% in 2022, its largest moves.
- Canopy Growth's EBITDA stood at -$91.1 million in 2021, then sank by 94.18% to -$176.8 million in 2022, then advanced by 13.57% to -$152.8 million in 2023, then soared by 88.84% to -$17.1 million in 2024, then slipped by 10.8% to -$18.9 million in 2025.
- The last three EBITDA figures came in at -$18.9 million (Q4 2025), -$12.3 million (Q3 2025), and -$16.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -98.81 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | -18.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -18.90 Mn |
| Sep 30, 2025 | -12.28 Mn |
| Jun 30, 2025 | -16.33 Mn |
| Mar 31, 2025 | -41.35 Mn |
| Dec 31, 2024 | -17.05 Mn |
| Sep 30, 2024 | -33.68 Mn |
| Jun 30, 2024 | -21.28 Mn |
| Mar 31, 2024 | -79.21 Mn |
| Dec 31, 2023 | -152.82 Mn |
| Sep 30, 2023 | -252.89 Mn |
| Jun 30, 2023 | -25.94 Mn |
| Mar 31, 2023 | -455.53 Mn |
| Dec 31, 2022 | -176.81 Mn |
| Sep 30, 2022 | -226.61 Mn |
| Jun 30, 2022 | -1.62 Bn |
| Mar 31, 2022 | -473.57 Mn |
| Dec 31, 2021 | -91.06 Mn |
| Sep 30, 2021 | 18.28 Mn |
| Jun 30, 2021 | 297.05 Mn |
| Mar 31, 2021 | -535.96 Mn |